Company Snapshot: SCIO  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Scios Announces Webcast to Discuss Third Quarter 2002 Results

    SUNNYVALE, Calif., Oct. 4 /PRNewswire-FirstCall/ --
Scios Inc. (Nasdaq: SCIO) today announced that the company will host a webcast
to discuss its third quarter results on Thursday, October 24, 2002, from
10:00 - 11 :00 a.m. Eastern Standard Time.
    To access the webcast, participants should go to the Scios Web site:
http://www.sciosinc.com.  The webcast will be archived on the Scios site for one week
through October 31, 2002.

    About Scios
    Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease.  The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.



SOURCE Scios Inc.




Back to Topback to top

Related links:
  • http://www.sciosinc.com
    CONTACT:
    Suzanne Beveridge of Scios Inc.,
    +1-408-616-2947; or media, Jim Weiss of WeissCom Partners,
    +1-415-260-1274; or investors, Fern Lazar of Lazar Partners,
    +1-212-867-1765, both for Scios Inc.